Your browser doesn't support javascript.
loading
Real world efficacy of osimertinib in second line/beyond in patients with metastatic EGFR+ non-small cell lung cancer and role of paired tumour-plasma T790M testing at tyrosine kinase inhibitor resistance.
Ma, Jun; Tan, Sze Huey; Yin, Daniel Xing Cheng; Tran, Nguyen Tuan Anh; Tan, Gek San; Lai, Gillianne Geet Yi; Ang, Mei-Kim; Kanesvaran, Ravindran; Jain, Amit; Rajasekaran, Tanujaa; Tan, Eng-Huat; Lim, Tony Kiat Hon; Tan, Daniel Shao-Weng; Lim, Darren Wan-Teck; Ng, Quan Sing; Tan, Wan Ling.
Afiliação
  • Ma J; Division of Medical Oncology, National Cancer Centre Singapore, 11 Hospital Crescent, Singapore, Singapore.
  • Tan SH; Division of Clinical Trials and Epidemiological Sciences, National Cancer Centre Singapore, Singapore, Singapore.
  • Yin DXC; Division of General Surgery, Tan Tock Seng Hospital, Singapore, Singapore.
  • Tran NTA; Department of Diagnostic Radiology, Singapore General Hospital, Singapore, Singapore.
  • Tan GS; Department of Pathology, Singapore General Hospital, Singapore, Singapore.
  • Lai GGY; Division of Medical Oncology, National Cancer Centre Singapore, 11 Hospital Crescent, Singapore, Singapore.
  • Ang MK; SingHealth Duke-NUS Oncology Academic Clinical Programme, Duke-NUS Medical School, Singapore, Singapore.
  • Kanesvaran R; Division of Medical Oncology, National Cancer Centre Singapore, 11 Hospital Crescent, Singapore, Singapore.
  • Jain A; SingHealth Duke-NUS Oncology Academic Clinical Programme, Duke-NUS Medical School, Singapore, Singapore.
  • Rajasekaran T; Division of Medical Oncology, National Cancer Centre Singapore, 11 Hospital Crescent, Singapore, Singapore.
  • Tan EH; SingHealth Duke-NUS Oncology Academic Clinical Programme, Duke-NUS Medical School, Singapore, Singapore.
  • Lim TKH; Division of Medical Oncology, National Cancer Centre Singapore, 11 Hospital Crescent, Singapore, Singapore.
  • Tan DS; SingHealth Duke-NUS Oncology Academic Clinical Programme, Duke-NUS Medical School, Singapore, Singapore.
  • Lim DW; Division of Medical Oncology, National Cancer Centre Singapore, 11 Hospital Crescent, Singapore, Singapore.
  • Ng QS; SingHealth Duke-NUS Oncology Academic Clinical Programme, Duke-NUS Medical School, Singapore, Singapore.
  • Tan WL; Division of Medical Oncology, National Cancer Centre Singapore, 11 Hospital Crescent, Singapore, Singapore.
Transl Lung Cancer Res ; 12(4): 742-753, 2023 Apr 28.
Article em En | MEDLINE | ID: mdl-37197627
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Transl Lung Cancer Res Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Singapura
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Transl Lung Cancer Res Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Singapura